Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Medendorp

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Oncology|August 1, 1988
Alternating non-cross-resistant chemotherapy for metastatic hormone-independent breast cancerG T Budd, R Garcia, S Medendorp, et al.
Cleveland Clinic Journal of Medicine|January 1, 1994
Long-term follow-up of children after repair of atrial septal defectsJ Mandelik, D S Moodie, R Sterba, et al.
Journal of Biological Response Modifiers|June 1, 1990
Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanomaM J Caulfield, B Barna, S Murthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancyG T Budd, S Murthy, J Finke, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Oncology|August 1, 1988
Alternating non-cross-resistant chemotherapy for metastatic hormone-independent breast cancerG T Budd, R Garcia, S Medendorp, et al.
Cleveland Clinic Journal of Medicine|January 1, 1994
Long-term follow-up of children after repair of atrial septal defectsJ Mandelik, D S Moodie, R Sterba, et al.
Journal of Biological Response Modifiers|June 1, 1990
Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanomaM J Caulfield, B Barna, S Murthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancyG T Budd, S Murthy, J Finke, et al.
Pageof 1